Alyssa Toorop

Research output

Research output per year 2017 2021 2022 2023 2023

• 16 Article
• 2 Comment/Letter to the editor
• 1 Review article
• 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort

  de Ruiter, L. R. J., Loonstra, F. C., Jelgerhuis, J. R., Coerver, E. M. E., Toorop, A. A., van Leeuwen, I. C. E., Noteboom, S., Moraal, B., Strijbis, E. M. M., Schoonheim, M. M. & Uitdehaag, B. M. J., 1 Mar 2023, In: Multiple Sclerosis and Related Disorders. 71, 104568.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis

  Toorop, A. A., van Kempen, Z. L. E., Steenhuis, M., Nielsen, J., Sinnige, L. G. F., van Dijk, G., Roosendaal, C. M., Arnoldus, E. P. J., Hoitsma, E., Lissenberg-Witte, B. I., de Jong, B. A., Oosten, B. W. V., Strijbis, E. M. M., Uitdehaag, B. M. J., Rispens, T. & Killestein, J., 1 Jun 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 6, p. 482-486 5 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis

  Toorop, A. A., Hogenboom, L., Bloem, K., Kocyigit, M., Commandeur, N. W. M., Wijnants, A., Lissenberg-Witte, B. I., Strijbis, E. M. M., Uitdehaag, B. M. J., Rispens, T., Killestein, J. & van Kempen, Z. L. E., 1 Jun 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 6, p. 487-493 7 p., jnnp-2022-330793.

  Research output: Contribution to journal › Article › Academic › peer-review
  1 Citation (Scopus)

• Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

  the T2B! immunity against SARS-CoV-2 study group & T2B! immunity against SARS-CoV-2 study group, Jan 2023, In: Annals of neurology. 93, 1, p. 103-108 6 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)

  Toorop, A. A., van Lierop, Z. Y., Gelissen, L. M., Hoitsma, E., Zeinstra, E. M., van Rooij, L. C., van Munster, C. E., Vennegoor, A., Mostert, J. P., Wokke, B. H., Kalkers, N. F., Hoogervorst, E. L., van Eijk, J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L., Kloosterziel, M. E., & 16 othersArnoldus, E. P., van Dijk, G. W., Bouvy, W. H., Wessels, M. H., Boonkamp, L., Strijbis, E. M., van Oosten, B. W., De Jong, B. A., Lissenberg-Witte, B. I., Barkhof, F., Moraal, B., Teunissen, C. E., Rispens, T., Uitdehaag, B. M., Killestein, J. & van Kempen, Z. LE., 14 Nov 2023, (E-pub ahead of print) In: Journal of neurology, neurosurgery, and psychiatry.

  Research output: Contribution to journal › Article › Academic
  2 Citations (Scopus)
• 2022

  Fingerprick blood samples to measure serum natalizumab concentrations

  Toorop, A. A., Steenhuis, M., Loeff, F. C., Weijers, S. S., Killestein, J., Rispens, T. & Kempen, Z. L. E. V., 2022, (E-pub ahead of print) In: MULTIPLE SCLEROSIS JOURNAL.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?

  T2B! immunity against SARS-CoV-2 study group, 1 Jan 2022, In: Multiple Sclerosis and Related Disorders. 57, p. 103416 5 p., 103416.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  17 Citations (Scopus)

• Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis

  van Lierop, Z. Y. GJ., Noteboom, S., Steenwijk, M. D., van Dam, M., Toorop, A. A., van Kempen, Z. L. E., Moraal, B., Barkhof, F., Uitdehaag, B. M. J., Schoonheim, M. M., Teunissen, C. E. & Killestein, J., Dec 2022, In: MULTIPLE SCLEROSIS JOURNAL. 28, 14, p. 2231-2242 12 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis

  Toorop, A. A., van Lierop, Z. Y. G. J., Strijbis, E. M. M., Teunissen, C. E., Barkhof, F., Uitdehaag, B. M. J., van Kempen, Z. L. E. & Killestein, J., Jan 2022, In: Multiple Sclerosis and Related Disorders. 57, p. 103364 103364.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  3 Citations (Scopus)
• 2021

  Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab

  Toorop, A. A., van Lierop, Z. Y. G., Strijbis, E. E. M., Teunissen, C. E., Petzold, A., Wattjes, M. P., Barkhof, F., de Jong, B. A., van Kempen, Z. L. E. & Killestein, J., 1 Jan 2021, In: Neurology neuroimmunology & neuroinflammation. 8, 1

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  18 Citations (Scopus)

• Natalizumab concentrations during pregnancy in three patients with multiple sclerosis

  Toorop, A. A., Rispens, T., Strijbis, E. M. M., van Oosten, B. W., de Jong, B. A., Uitdehaag, B. M. J., Killestein, J. & van Kempen, Z. L. E., 2021, (E-pub ahead of print) In: MULTIPLE SCLEROSIS JOURNAL.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients

  van Lierop, Z. Y. G. J., Toorop, A. A., Coerver, E. M. E., Willemse, E. A. J., Strijbis, E. M. M., Kalkers, N. F., Moraal, B., Barkhof, F., Teunissen, C. E., Killestein, J. & van Kempen, Z. L. E., 2021, In: Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7, 2

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  12 Citations (Scopus)

• Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic

  van Lierop, Z. Y. GJ., Toorop, A. A., van Ballegoij, W. J. C., Olde Dubbelink, T. B. G., Strijbis, E. M. M., de Jong, B. A., van Oosten, B. W., Moraal, B., Teunissen, C. E., Uitdehaag, B. M. J., Killestein, J. & Kempen, Z. L. E. V., 2021, (E-pub ahead of print) In: Multiple sclerosis (Houndmills, Basingstoke, England).

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  32 Citations (Scopus)
• 2020

  Biphasic Glucocorticoid Rhythm in One-Month-Old Infants: Reflection of a Developing HPA-Axis?

  Hollanders, J. J., Van Der Voorn, B., De Goede, P., Toorop, A. A., Dijkstra, L. R., Honig, A., Rotteveel, J., Dolman, K. M., Kalsbeek, A. & Finken, M. J. J., 8 Jan 2020, In: Journal of clinical endocrinology and metabolism. 105, 3, dgz089.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  9 Citations (Scopus)

• Diurnal rhythmicity in breast-milk glucocorticoids, and infant behavior and sleep at age 3 months

  Toorop, A. A., van der Voorn, B., Hollanders, J. J., Dijkstra, L. R., Dolman, K. M., Heijboer, A. C., Rotteveel, J., Honig, A. & Finken, M. J. J., 1 Jun 2020, In: ENDOCRINE. 68, 3, p. 660-668 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  8 Citations (Scopus)
• 2019

  No association between glucocorticoid diurnal rhythm in breastmilk and infant body composition at 3months

  Hollanders, J. J., Dijkstra, L. R., van der Voorn, B., Kouwenhoven, S. M. P., Toorop, A. A., van Goudoever, J. B., Rotteveel, J. & Finken, M. J. J., 2 Oct 2019, In: NUTRIENTS. 11, 10

  Research output: Contribution to journal › Article › Academic › peer-review